Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%
$54.50
$37.28
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$11.90
+3.4%
$13.44
$6.43
$17.15
$346.03M0.97195,780 shs190,272 shs
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$30.00
$29.81
$28.87
$30.04
$846M1685,938 shsN/A
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
$19.86
$18.12
$5.80
$20.96
$2.09B2.081.87 million shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+3.19%
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
0.00%+5.50%-13.83%-6.30%+49.69%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.00%0.00%0.00%0.00%+1.39%
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
0.00%0.00%0.00%0.00%+7.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
$54.65
+0.2%
$54.50
$37.28
$57.35
$4.50B-0.41.86 million shs15.31 million shs
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$11.90
+3.4%
$13.44
$6.43
$17.15
$346.03M0.97195,780 shs190,272 shs
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$30.00
$29.81
$28.87
$30.04
$846M1685,938 shsN/A
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
$19.86
$18.12
$5.80
$20.96
$2.09B2.081.87 million shsN/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
0.00%0.00%0.00%0.00%+3.19%
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
0.00%+5.50%-13.83%-6.30%+49.69%
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.00%0.00%0.00%0.00%+1.39%
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
0.00%0.00%0.00%0.00%+7.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
2.00
Hold$60.009.79% Upside
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
2.75
Moderate Buy$20.2970.47% Upside
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.00
N/AN/AN/A
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ENTA, TRIL, AKRO, and RDUS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/20/2026
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
Reiterated RatingSell (D-)
3/26/2026
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
Initiated CoverageBuy$20.00
(Data available from 6/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/A$10.75 per shareN/A
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
$65.32M5.30N/AN/A$3.03 per share3.93
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$2.74B0.31$0.73 per share40.96$18.73 per share1.60
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
$150K13,903.44N/AN/A$2.56 per share7.76
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
-$252.06M-$1.94N/AN/AN/AN/A-15.86%-14.78%N/A
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
-$81.89M-$2.59N/AN/AN/A-89.56%-64.04%-20.22%8/10/2026 (Confirmed)
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
-$266.41M-$3.60N/AN/AN/A-3.69%-15.73%-6.01%N/A
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
-$59.35M$0.6232.04N/AN/AN/A-23.31%-18.66%N/A

Latest ENTA, TRIL, AKRO, and RDUS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/11/2026Q2 2026
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
-$0.46-$0.45+$0.01-$0.45$17.03 million$17.16 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/AN/AN/AN/AN/A
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
N/AN/AN/AN/AN/A
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
$0.752.50%N/AN/A N/A
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
N/A
15.84
15.83
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
N/A
3.84
3.84
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
0.85
1.85
0.97
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
N/A
19.82
19.82
CompanyEmployeesShares OutstandingFree FloatOptionable
Akero Therapeutics, Inc. stock logo
AKRO
Akero Therapeutics
3082.32 million76.50 millionOptionable
Enanta Pharmaceuticals, Inc. stock logo
ENTA
Enanta Pharmaceuticals
16029.08 million25.74 millionOptionable
Radius Recycling, Inc. stock logo
RDUS
Radius Recycling
3,01128.20 million26.82 millionNo Data
Defiance Trillion Dollar Club Index ETF stock logo
TRIL
Defiance Trillion Dollar Club Index ETF
33105.00 million95.44 millionNo Data

Recent News About These Companies

ETF Prime: Murphy on the New Faces of the ETF Boom
Defiance Trillion Dollar Club Index ETF
Tidal Trust II - Defiance Trillion Dollar Club Index ETF
Trillium Therapeutics Stock Price History
TTI Consumer Power Tools, Inc. is Seeking an IP Paralegal
Advances in Drug Discovery & Development 2024
Cachet Bicycle shakes off COVID
BridgeBio raises $1.25bn, and other biotech financings
Ratio Therapeutics Raises $50M in Series B Financing

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Akero Therapeutics stock logo

Akero Therapeutics NASDAQ:AKRO

Akero Therapeutics, Inc., together with its subsidiary, engages in the development of treatments for patients with serious metabolic diseases in the United States. The company's lead product candidate is efruxifermin (EFX), which is in Phase 3 clinical trials that protects against cellular stress and regulates the metabolism of lipids, carbohydrates, and proteins throughout the body for the treatment of biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients. It has a license agreement with Amgen Inc. to develop, manufacture, use, distribute, and sell EFX as a treatment for MASH and other metabolic diseases. The company was formerly known as Pippin Pharmaceuticals, Inc. and changed its name to Akero Therapeutics, Inc. in May 2018. Akero Therapeutics, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California.

Enanta Pharmaceuticals stock logo

Enanta Pharmaceuticals NASDAQ:ENTA

$11.90 +0.39 (+3.39%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$11.92 +0.02 (+0.17%)
As of 06/12/2026 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; EDP-938 and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; and Glecaprevir, which is in the market for the treatment of chronic infection with hepatitis C virus or HCV. The company has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. Enanta Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Watertown, Massachusetts.

Radius Recycling stock logo

Radius Recycling NASDAQ:RDUS

Radius Recycling, Inc. recycles ferrous and nonferrous metal, and manufactures finished steel products worldwide. The company acquires, processes, and recycles salvaged vehicles, rail cars, home appliances, industrial machinery, manufacturing scrap, and construction and demolition scrap. It offers recycled ferrous metal, a feedstock used in the production of finished steel products; and nonferrous products, including mixed metal joint products recovered from the shredding process, such as zorba, zurik, aluminum, copper, stainless steel, nickel, brass, titanium, lead, and high temperature alloys. The company also procures salvaged vehicles and sells serviceable used auto parts from these vehicles through its retail self-service auto parts stores. In addition, it produces various finished steel products using ferrous recycled metal and other raw materials, as well as semi-finished goods, which include billets; and finished goods consisting of rebar, coiled rebar, wire rods, merchant bars, and other specialty products. Further, the company sells catalytic converters to specialty processors that extract the nonferrous precious metals, including platinum, palladium, and rhodium; and ferrous and nonferrous recycled metal products to steel mills, foundries, refineries, smelters, wholesalers, and recycled metal processors, as well as finished steel customers, such as steel service centers, construction industry subcontractors, steel fabricators, wire drawers, and major farm and wood products suppliers. It also provides recycling and related services, including scrap brokerage, certified destruction, automotive parts recycling, railcar dismantling, and reverse logistics under 3PR brand name. Radius Recycling, Inc. was formerly known as Schnitzer Steel Industries, Inc. and changed its name to Radius Recycling, Inc. in January 2024. Radius Recycling, Inc. was founded in 1906 and is headquartered in Portland, Oregon.

Defiance Trillion Dollar Club Index ETF stock logo

Defiance Trillion Dollar Club Index ETF NASDAQ:TRIL

Trillium Therapeutics, Inc. is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. It offers clinical programs, TTI-621 and TTI-622, target CD47, a signal that cancer cells frequently use to evade the immune system. The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.